SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-16-000931
Filing Date
2016-06-22
Accepted
2016-06-22 16:26:23
Documents
8
Period of Report
2016-06-17
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR 06-17-2016 form_8-k.htm 8-K 26396
2 DESIGNATION OF SERIES A PREFERRED STOCK ex_4-1.htm EX-4 982
3 PRESS RELEASE ex_99-1.htm EX-99 5261
4 GRAPHIC angiosoma_logo.jpg GRAPHIC 28901
5 GRAPHIC ex4-1_1.jpg GRAPHIC 271105
6 GRAPHIC ex4-1_2.jpg GRAPHIC 363943
7 GRAPHIC ex4-1_3.jpg GRAPHIC 370156
8 GRAPHIC ex4-1_4.jpg GRAPHIC 272189
  Complete submission text file 0001161697-16-000931.txt   1834122
Mailing Address 14001 WALDEN RD., SUITE 600 MONTGOMERY TX 77356
Business Address 14001 WALDEN RD., SUITE 600 MONTGOMERY TX 77356 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 161726826
SIC: 1311 Crude Petroleum & Natural Gas